NCT02946606View on ClinicalTrials.gov

A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 30, 2016

Study Completion Date

December 30, 2016

Conditions
Adult Growth Hormone Deficiency
Interventions
DRUG

GX-H9

Human growth hormone

DRUG

Genotropin

Human growth hormone

Trial Locations (1)

Unknown

Severance Hospital, Seoul

Sponsors

Lead Sponsor

Genexine, Inc.
All Listed Sponsors
lead

Genexine, Inc.

INDUSTRY

NCT02946606 - A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9 | Biotech Hunter | Biotech Hunter